「including」の検索結果

Manages Power BI semantic models, including tables, columns, measures, relationships, field parameters, DAX, Import, DirectQuery and Direct Lake designs, sources, connections, permissions, refresh, and deployment. Load this skill before acting on a semantic model, unless it is part of publishing a PBIP project, which powerbi-report-cli owns. For natural-language data questions use fabriciq; for visuals use powerbi-report-cli.

日本語の概要は準備中です。原文の説明を表示しています。

Manages Fabric Spark work, including notebook cell code with %%configure, %%sql, PySpark and notebookutils, named notebook runs, Livy sessions, triage of failed or OOM notebook and pipeline Spark runs, and the Materialized Lake View (MLV) lifecycle. Load it before writing MLV SQL, since CREATE MATERIALIZED LAKE VIEW and its CONSTRAINT clause are Fabric-only. KQL materialized views belong to eventhouse-cli.

日本語の概要は準備中です。原文の説明を表示しています。

Manages a Fabric SQL database item, the OLTP SQL Server engine, including running T-SQL through sqlcmd, temporal and vector similarity search, schema and sys.tables inspection, dacpac deployment, and Query Store, blocked sessions and regressed-plan investigation. Use for any query or change against a SQL database item. Warehouse, lakehouse SQL endpoint and mirrored items belong to sqldw-cli.

日本語の概要は準備中です。原文の説明を表示しています。

Manages Fabric IQ Ontology items, including entity and relationship types, data bindings, and definition updates, plus schema, lineage, grounding, and graph-walk exploration. Use for ontology modelling and traversal. For natural-language questions over a Power BI report use fabriciq.

日本語の概要は準備中です。原文の説明を表示しています。

Answers natural-language business questions over existing Power BI reports and semantic models through the FabricIQ MCP endpoint, discovering artifacts, resolving entities, generating the DAX itself, and returning a plain-language answer. Use when the user asks a data question, including one that says to query the model directly. For DAX the user supplies, or measures to save, use semantic-model-authoring.

日本語の概要は準備中です。原文の説明を表示しています。

Drive and verify an Electron or Tauri desktop app from the inside, including the main-process and Rust IPC calls a browser tool cannot see. Use when a desktop app needs testing, when a feature works in the browser but not in the packaged app, when an IPC or invoke call needs proving, when a desktop screenshot or visual diff is wanted, or when you need a headless run of a desktop UI in CI.

日本語の概要は準備中です。原文の説明を表示しています。

Use the skill to control and verify the code interface configuration of your model — how Simulink® model elements are represented in the generated C or C++ code. This includes — (1) specifying names, types (storage classes), and placement of variables that represent model elements (for example, making a model parameter tunable as a global extern variable); (2) specifying names, types, and placement of functions that represent model algorithms; (3) selecting the deployment type (Component, Subcomponent, or Automatic); (4) selecting the interface configuration type (data or service interface); (5) linking a shared Embedded Coder dictionary to a model; (6) creating Embedded Coder dictionary entries and setting their properties; (7) for service interface configuration — specifying service interface definitions, including sender, receiver, client, and server services. Items 1 and 2 can be set per element or as a category-wide default. Item 1 applies to GRT and ERT models; the rest to ERT models only.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill when authoring, reworking, or validating a Classic AUTOSAR software component (SWC) in Simulink, including autosar.api mappings, runnables, timing events, sender-receiver ports, client-server operations, IRVs, BSW service callers, and component ARXML updates.

日本語の概要は準備中です。原文の説明を表示しています。

Modern .NET project structure including .slnx solution format, Directory.Build.props, central package management, SourceLink, version management with RELEASE_NOTES.md, and SDK pinning with global.json.

日本語の概要は準備中です。原文の説明を表示しています。

Create and maintain AGENTS.md / CLAUDE.md snippet indexes that route tasks to the correct dotnet-skills skills and agents (including compressed Vercel-style indexes).

日本語の概要は準備中です。原文の説明を表示しています。

Entity Framework Core best practices including NoTracking by default, query splitting for navigation collections, migration management, dedicated migration services, and common pitfalls to avoid.

日本語の概要は準備中です。原文の説明を表示しています。

Microsoft.Extensions.Options patterns including IValidateOptions, strongly-typed settings, validation on startup, and the Options pattern for clean configuration management.

日本語の概要は準備中です。原文の説明を表示しています。

Critical Akka.NET best practices including EventStream vs DistributedPubSub, supervision strategies, error handling, Props vs DependencyResolver, work distribution patterns, and cluster/local mode abstractions for testability.

日本語の概要は準備中です。原文の説明を表示しています。

Detects m6A modifications from Oxford Nanopore direct-RNA-seq (DRS) signal using m6Anet (multiple-instance-learning over DRACH 5-mer signal). Covers the upstream pipeline (Dorado/Guppy basecalling -> minimap2 map-ont -> nanopolish eventalign -> m6anet dataprep -> m6anet inference), per-site vs per-read probability including the mod_ratio stoichiometry column, the DRACH-only constraint, minimum-coverage thresholds (20-50 reads/site), multi-condition comparison via xPore/Nanocompore/ELIGOS, Dorado native modification calling (RNA004, 2024+), and the cDNA-vs-DRS distinction (cDNA Nanopore CANNOT detect modifications). Use when calling m6A from ONT DRS without immunoprecipitation, choosing m6Anet vs xPore vs Nanocompore vs ELIGOS vs Dorado native, interpreting probability_modified vs mod_ratio vs per-read probabilities, deciding between m6Anet (known DRACH sites) and Dorado/Remora (genome-wide screening), pinning RNA002 vs RNA004 chemistry and basecaller versions, or troubleshooting eventalign/dataprep failures.

日本語の概要は準備中です。原文の説明を表示しています。

Performs differential expression on bulk RNA-seq count data with DESeq2's negative-binomial GLM, Wald and LRT testing, apeglm/ashr/normal LFC shrinkage, independent filtering, Cook's outlier handling, VST/rlog transforms, and design formulas including paired, batch, and interaction terms. Use when running bulk DE, choosing DESeq2 over edgeR or limma-voom, building a paired or interaction design, applying LFC shrinkage for ranking or GSEA, choosing Wald vs LRT, troubleshooting padj=NA, picking VST vs rlog, importing salmon/kallisto via tximport, or analyzing prokaryotic RNA-seq.

日本語の概要は準備中です。原文の説明を表示しています。

Compose multi-panel publication figures with patchwork, cowplot, gridExtra (R), or matplotlib GridSpec/subfigures (Python) including shared axes/legends/guides collection, panel labels in Nature/Cell convention, and journal-spec sizing. Covers patchwork ≥1.2.0 axes='collect' feature, Type-42 font embedding, and the cairo_pdf save path. Use when composing 2+ subpanels into a single figure for journal submission.

日本語の概要は準備中です。原文の説明を表示しています。

Build whole-genome alignments using Progressive Cactus (Armstrong 2020 reference-free clade-level WGA), Minigraph-Cactus (Hickey 2024 pangenome-aware), LASTZ chain/net (UCSC pipeline), MUMmer4 (Marçais 2018 pairwise), minimap2 -x asm5/10/20 (Li 2018 fast pairwise), AnchorWave (Song 2022 WGD-aware), and Mauve / progressiveMauve (bacterial). Operates the HAL toolkit (Hickey 2013) for downstream extraction including halSynteny, halLiftover, halBranchMutations, and hal2maf. Use when constructing multi-species alignments for comparative-annotation projection (TOGA), synteny detection, conservation analyses (phyloP / PhastCons), or pangenome graph construction; selecting between reference-free (Cactus) and reference-anchored (LASTZ chains/nets) approaches; tuning sensitivity for closely vs distantly related genomes; or producing HAL files for genome-wide downstream tools.

日本語の概要は準備中です。原文の説明を表示しています。

Batch effect correction for CRISPR screens covering ComBat empirical-Bayes, RUV, SVA, control-sgRNA normalization, and the model-based alternative of including batch as a covariate in MAGeCK MLE or Chronos. Covers screen-specific batch sources (passage cohort, library lot, infection day, sequencing run, Cas9 lot, FBS lot), PCA + variance-decomposition diagnostic to decide if correction is needed, when correction harms biology by over-correcting condition into batch, limma removeBatchEffect for visualization-only correction, and relationship to multi-condition design matrices. Use when combining screens for joint analysis, when passage cohort confounds biology, when DepMap-style panels need Chronos with batch covariates, when picking ComBat vs RUV, or when correction harms biology and should be replaced with explicit covariate modeling.

日本語の概要は準備中です。原文の説明を表示しています。

Performs alchemical free-energy calculations including relative binding free energy (RBFE / FEP+) and absolute binding free energy (ABFE) via OpenFE, FEP+, GROMACS, AMBER pmemd, and OpenMM with explicit lambda scheduling, soft-core potentials, MBAR/BAR analysis, cycle-closure validation, and protocol-appropriate enhanced sampling. Compares ML alternatives (Boltz-2 affinity, DeepDock). Use when ranking analogs by binding affinity beyond docking accuracy, performing prospective lead optimization, or validating SAR predictions.

日本語の概要は準備中です。原文の説明を表示しています。

Implements missing-data sensitivity analyses for confirmatory clinical trials including MMRM under MAR (with Kenward-Roger correction), reference-based multiple imputation (J2R, CR, CIR, LMCF per Carpenter-Roger 2013), Permutt delta-adjustment / tipping-point analysis, pattern-mixture identifying restrictions (CCMV, NCMV, ACMV), and the Cro vs Bartlett variance debate. Use when handling missing primary or secondary endpoint data in regulatory submissions following NRC 2010 and ICH E9(R1).

日本語の概要は準備中です。原文の説明を表示しています。

Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.

日本語の概要は準備中です。原文の説明を表示しています。

Predicts ADMET properties using ADMETlab 3.0 (119 platform features, including 77 prediction models with modeled-endpoint uncertainty), ADMET-AI, DeepChem MolNet, and chemprop D-MPNN with explicit handling of OECD QSAR principles, applicability domain assessment, calibration, hERG/CYP/AMES endpoints, and PAINS / Lipinski / Ro5 / Veber / BBB druglikeness filters. Use when filtering compounds for drug-likeness, prioritizing leads by predicted safety, or building an in-house ADMET QSAR model.

日本語の概要は準備中です。原文の説明を表示しています。

Identifies differentially bound ChIP-seq regions between conditions using DiffBind, csaw (sliding windows), DESeq2/edgeR/PyDESeq2 on count matrices, NormR (control-aware), or MAnorm2. Distinguishes three distinct normalization problems (composition bias, trended bias, global shifts) and matches each to its appropriate fix including spike-in scaling. Use when comparing ChIP-seq binding between experimental conditions, choosing normalization for global vs local changes, integrating spike-in data, or reconciling DiffBind/DESeq2 disagreement.

日本語の概要は準備中です。原文の説明を表示しています。

Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.

日本語の概要は準備中です。原文の説明を表示しています。